Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report

Pingguo Duan, Yonghong Sheng, Chang-Hao Deng, Benyu Tang, Haoqun Yao

BMC Musculoskeletal Disorders · 2020 · 10 citations · 15 references

DOIFull text

Open access

Abstract

Denosumab therapy contributed to tumour regression. Three-level TES may be an effective and feasible strategy for managing large recurrent GCTs of the spine after denosumab therapy.

References

15